Contributed by Uyen (May 10, 2013) | I recently finished a book called “Never Eat Alone” by Keith Ferrazzi, a successful businessman and an acclaimed “relationship guru,” and in his book there was a chapter titled “Balance is B.S.” In this chapter, Keith outlined his daily schedule where he wakes up at 4 AM to juggle phone calls and emails for three hours before going off to business meetings all day. Keith ends his day with dinner and drinks with friends until the late hours - all to start the following day at 4 AM again.
Philip Clifford, Ph.D.
Dr. Philip Clifford is Associate Dean of the Graduate School of Biomedical Sciences and Professor of Anesthesiology and Physiology at the Medical College of Wisconsin. He is an outspoken advocate for postdoctoral education at local and national levels and a strong proponent of career planning for Ph.D.
HELPING BRILLIANT PEOPLE SHARE BRILLIANT IDEAS.
Spoken Science is an independent consulting company, dedicated to helping scientists, science educators, and professionals in technical fields share ideas as broadly and powerfully as possible.
Center for Technology Commercialization
The Center for Technology Commercialization (CTC) provides entrepreneurs with access to a statewide network of resources and expertise, identifies high-potential entrepreneurs and helps move their businesses forward, facilitates collaboration between entrepreneurs and between organizations that assist entrepreneurs, and helps create and grow minority-owned businesses.
Facilitating scientific discovery through data visualization.
Artist and Scientist H. Adam Steinberg founded artforscience to help faculty and scientists communicate their research data for books, grants, talks, publications, posters, or for their websites
Quintessence Biosciences, Inc. is a biopharmaceutical company focused on development of novel protein-based therapeutics as anti-cancer agents. The company’s products are based on the EVade™ Ribonuclease Technology which allows for the engineering of human proteins (ribonucleases) for the treatment of human diseases.
'Seeking to Redefine What is Possible IN the Treatment of CNS Disorders'
Promentis Pharmaceuticals, Inc. is a pharmaceutical company developing novel compounds for the treatment of schizophrenia and other central nervous system disorders. Promentis’ drug development efforts are focused on the neurotransmitter glutamate and its critical role in the pathophysiology of schizophrenia and other diseases.